ZYTO Corp. Announces Activity in Pursuit of NASDAQ Stock Listing

ZYTO Corp. is pursuing a course to list company stock on NASDAQ. The company currently trades in the pink sheets.

Orem, UT, May 31, 2007 --(PR.com)-- ZYTO Corp. (OTC - ZYTC.pk) has announced that plans are progressing forward to list the company’s stock with NASDAQ.

“We are aggressively pursuing full reporting with the SEC and listing as a NASDAQ company. We are currently in the financial audit process and will be filing with the Securities and Exchange Commission as quickly as we can,” explained CEO Dr. Vaughn Cook, founder of the company.

“We recognize the process takes time and we cannot guarantee the outcome, but we are committed to the process.” said Cook.

The company has already seen rapid growth over the past year, and has doubled in size. Cook is predicting continued growth as more and more health professionals discover ZYTO (tm) technology.

Cook received a patent pending on the technology that enables computers and human bodies to communicate. Healthcare practitioners are able to use the ZYTO technology to gather information. Even though this process has clinical value, instruments using the ZYTO technology are not medical devices.

The successful marketing plan involves a strategic alliance with key nutriceutical companies, referred to by ZYTO as SAM's (Strategic Alliance Members). These alliance companies give ZYTO access to the healthcare professionals who are their customers. ZYTO offers those healthcare professionals the opportunity to receive, be trained on, and evaluate the ZYTO Balance System for a 30-day period, free of any charge or obligation to purchase.

The growing number of SAMs have brought a rapid increase in sales to the company. "We have found that most practitioners who take advantage of the SAM opportunity discover that our technology is an indispensable addition to their practice," explained Cook.

The company has a web site at http://www.ZYTO.com

About ZYTO Corp.
ZYTO Corp. was founded by Dr. Vaughn Cook, OMD. The company provides computerized bio-technology equipment and software with clinical applications that include obtaining information from the human body to assist healthcare practitioners to make better decisions.

Forward Looking Statement:
Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, continued acceptance of the Company's products, increased levels of competition for the Company, new products and technological changes, the Company's dependence upon third-party suppliers, intellectual property rights, and other risks detailed from time to time in the Company's periodic reports the Company may file.

Press Contact:
David M. Bresnahan
801-224-7199

Video and Interviews:
Broadcast quality video of the ZYTO technology is available on request in all formats. Radio interviews are available by phone with Dr. Cook.

###
Contact
Zyto Corp.
Dr. Vaughn Cook
801-224-7199
www.zyto.com
ContactContact
Categories